Top Markets
Coin of the day
Medibio Limited Medibio Limited

Medibio Limited

MEB
Rank in Stocks #40211
Medibio Limited is a health technology firm dedicated to the identification and... Medibio Limited is a health technology firm dedicated to the identification and screening of mental health conditions, serving clients in Australia and the United States. The company provides mental well-being programs for corporations through its corporate health product line and also innovates solutions for the healthcare provider market. Founded in 1987, the enterprise was initially known as BioProspect Limited before rebranding to Medibio Limited in November 2014. Its headquarters are situated in Melbourne, Australia.
Share Price
$0.01672346
Last synced: 2023-11-02
Market Cap
$207.65K
Change (1 day)
30.48%
Change (1 year)
0.00%
Country
AU
Trade Medibio Limited (MEB)

Category

P/E ratio for Medibio Limited (MEB)
P/E ratio as of 2026 TTM: 0
According to Medibio Limited latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Medibio Limited from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.